GR1003359B - Λιποσωμιακο νιφλουμικο οξυ - νεο διαδερμικο αντιφλεγμονωδες φαρμακο [κεφαλη ψαροτουφεκου - Google Patents

Λιποσωμιακο νιφλουμικο οξυ - νεο διαδερμικο αντιφλεγμονωδες φαρμακο [κεφαλη ψαροτουφεκου

Info

Publication number
GR1003359B
GR1003359B GR980100469A GR980100469A GR1003359B GR 1003359 B GR1003359 B GR 1003359B GR 980100469 A GR980100469 A GR 980100469A GR 980100469 A GR980100469 A GR 980100469A GR 1003359 B GR1003359 B GR 1003359B
Authority
GR
Greece
Prior art keywords
encapsulated
medecine
liposomes
niflumic acid
encapsulation
Prior art date
Application number
GR980100469A
Other languages
Greek (el)
English (en)
Inventor
Original Assignee
�.�. ����������� �.�.�.�.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by �.�. ����������� �.�.�.�., filed Critical �.�. ����������� �.�.�.�.
Publication of GR1003359B publication Critical patent/GR1003359B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A61K9/1278—Post-loading, e.g. by ion or pH gradient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
GR980100469A 1998-12-24 1998-12-24 Λιποσωμιακο νιφλουμικο οξυ - νεο διαδερμικο αντιφλεγμονωδες φαρμακο [κεφαλη ψαροτουφεκου GR1003359B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR98100469 1998-12-24

Publications (1)

Publication Number Publication Date
GR1003359B true GR1003359B (el) 2000-04-10

Family

ID=10943556

Family Applications (1)

Application Number Title Priority Date Filing Date
GR980100469A GR1003359B (el) 1998-12-24 1998-12-24 Λιποσωμιακο νιφλουμικο οξυ - νεο διαδερμικο αντιφλεγμονωδες φαρμακο [κεφαλη ψαροτουφεκου

Country Status (17)

Country Link
EP (1) EP1140089A1 (is)
JP (1) JP2002533394A (is)
KR (1) KR20010089889A (is)
CN (1) CN1331592A (is)
AU (1) AU1673400A (is)
BR (1) BR9917006A (is)
CA (1) CA2357765A1 (is)
CZ (1) CZ20012240A3 (is)
GR (1) GR1003359B (is)
HU (1) HUP0104853A3 (is)
IL (1) IL143499A0 (is)
IS (1) IS5964A (is)
MX (1) MXPA01006462A (is)
NO (1) NO20013015D0 (is)
PL (1) PL349344A1 (is)
SK (1) SK7962001A3 (is)
WO (1) WO2000038681A1 (is)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4874547B2 (ja) * 2002-11-26 2012-02-15 ギリアード サイエンシーズ， インコーポレイテッド 勾配によるリポソームへの薬物充填方法
WO2004096140A2 (en) 2003-04-25 2004-11-11 The Penn State Research Foundation Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds
US20050255154A1 (en) 2004-05-11 2005-11-17 Lena Pereswetoff-Morath Method and composition for treating rhinitis
JP4791082B2 (ja) * 2005-05-30 2011-10-12 株式会社クラレ リポソームおよびそれを含む皮膚外用剤
JP4931369B2 (ja) * 2005-05-31 2012-05-16 ポーラ化成工業株式会社 リポソームおよびそれを含む処置用の組成物
ES2462541T3 (es) 2005-06-09 2014-05-23 Meda Ab Método y composición para el tratamiento de trastornos inflamatorios
EP2598128B1 (en) 2010-07-28 2018-03-28 Life Technologies Corporation Anti- viral azide-containing compounds
US20120028335A1 (en) 2010-07-28 2012-02-02 Life Technologies Corporation Anti-viral azide-containing compounds
SG11201404361UA (en) 2012-01-26 2014-09-26 Life Technologies Corp Methods for increasing the infectivity of viruses

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4528193A (en) * 1978-12-27 1985-07-09 A. Natterman & Cie. Gmbh Inflammation-preventing pharmaceutical composition of oral administration
EP0225162A2 (en) * 1985-11-27 1987-06-10 Ethicon, Inc. Inhibition of post-surgical adhesion formation by the topical administration of non-steroidal anti-inflammatory drug
EP0249561A2 (en) * 1986-06-12 1987-12-16 The Liposome Company, Inc. Compositions using liposome-encapsulated non-steroidal anti-inflammatory drugs
WO1996032930A1 (en) * 1995-04-18 1996-10-24 Yissum Research Development Company Of The Hebrew University Of Jerusalem Liposome drug-loading method and composition

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4528193A (en) * 1978-12-27 1985-07-09 A. Natterman & Cie. Gmbh Inflammation-preventing pharmaceutical composition of oral administration
EP0225162A2 (en) * 1985-11-27 1987-06-10 Ethicon, Inc. Inhibition of post-surgical adhesion formation by the topical administration of non-steroidal anti-inflammatory drug
EP0249561A2 (en) * 1986-06-12 1987-12-16 The Liposome Company, Inc. Compositions using liposome-encapsulated non-steroidal anti-inflammatory drugs
WO1996032930A1 (en) * 1995-04-18 1996-10-24 Yissum Research Development Company Of The Hebrew University Of Jerusalem Liposome drug-loading method and composition

Also Published As

Publication number Publication date
CA2357765A1 (en) 2000-07-06
NO20013015L (no) 2001-06-18
KR20010089889A (ko) 2001-10-12
NO20013015D0 (no) 2001-06-18
EP1140089A1 (en) 2001-10-10
MXPA01006462A (es) 2002-06-04
IL143499A0 (en) 2002-04-21
HUP0104853A2 (hu) 2002-05-29
HUP0104853A3 (en) 2003-05-28
AU1673400A (en) 2000-07-31
CZ20012240A3 (cs) 2001-11-14
PL349344A1 (en) 2002-07-15
CN1331592A (zh) 2002-01-16
JP2002533394A (ja) 2002-10-08
SK7962001A3 (en) 2002-02-05
WO2000038681A1 (en) 2000-07-06
IS5964A (is) 2001-06-08
BR9917006A (pt) 2001-10-30

Similar Documents

Publication Publication Date Title
Patel et al. An overview of phytosomes as an advanced herbal drug delivery system
Kumar et al. A review on phytosomes: novel approach for herbal phytochemicals
US5043323A (en) Complex compounds of bioflavonoids with phospholipids, their preparation and use, and pharmaceutical and cosmetic compositions containing them
US8569247B2 (en) Hydrolysate of crocin
Rathore et al. Planterosomes: A potential phyto-phospholipid carriers for the bioavailability enhancement of herbal extracts
Kumar et al. Phytosomes as emerging nanotechnology for herbal drug delivery
CN105395469A (zh) 活性物质的冻干组合物
Udapurkar et al. Phyto-phospholipid complex vesicles for phytoconstituents and herbal extracts: A promising drug delivery system
CN104997652A (zh) 一种抗皱保湿脂质体及其制备方法和应用
GR1003359B (el) Λιποσωμιακο νιφλουμικο οξυ - νεο διαδερμικο αντιφλεγμονωδες φαρμακο [κεφαλη ψαροτουφεκου
Nimbalkar et al. Phytosomes-novel drug delivery system
Varde et al. Phytosomes: a potential phospholipid nanoparticulate carrier for the bioavailability enhancement of herbal extracts
Singh et al. Phyto-phospholipid complexes: a potential novel carrier system for improving bioavailability of phytoconstituents
Ravi et al. Phytosomes: a novel molecular nano complex between phytomolecule and phospholipid as a value added herbal drug delivery system
EP1609461A1 (en) Cosmetic compositions comprising a mixture of N-acyl-phosphatidylethanolamines and cosmetic treatments thereof.
AU2016250068B2 (en) One-step method for production of Ultra-small Lipid Structures
Singh et al. Herbal bioactive: A booster dose for advanced pharmaceutical nanoscience
Kamireddy et al. Phytosomal drug delivery system: A detailed study
KR20110114068A (ko) 비타민 복합체, 이를 제조하는 방법 및 이를 포함하는 화장료 조성물
BRPI1105312B1 (pt) Composições farmacêuticas compreendendo extrato de arrabidaea chica, verlot em sistemas de liberação micro e nanoparticulados e lipossomais, processos de fabricação e uso dos mesmos
CN114681346A (zh) 一种苦杏仁苷脂质体、其制备方法和在化妆品中的应用
KR920008159B1 (ko) 생리활성 플라보노이드 리포좀의 제조방법
JPH0624999A (ja) リポソーム製剤
CN113785975B (zh) 精胺、亚精胺脂质体在抗氧化、抗衰老中的应用
JP2002212071A (ja) 経口表皮透過バリア機能改善剤

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees